AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
A California biotech company, StemLifeLine, is peddling a service that offers to transform "spare embryos" into stem-cell lines that clients "may one day use to create personalized therapies for themselves and their families."
StemLifeLine admits on its FAQs page that "the stem cells most commonly used in therapy are adult stem cells." Also, the company will not guarantee that it can create a stem-cell line out of the 10 necessary embryos that would need to be cannibalized in the process. However, StemLifeLine claims to have successfully completed pilot studies that validate its service offering. But since no therapeutic application of embryonic stem cells has yet to be found anywhere in the world, it seems unlikely, particularly considering that the use of non-embryonic stem cells, ...